Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 27/01/20111 min de leitura
Drug-Induced Liver Injury: Are We Ready to Look?; Public Conference; Request for Comments
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing a public conference entitled "Drug-Induced Liver Injury: Are We Ready to Look?" The public conference will be cosponsored with the American Association for the Study of Liver Diseases (AASLD) and the Pharmaceutical and Research Manufacturers of America to discuss and debate issues regarding drug-induced liver injury (DILI). The purpose of this conference is to consider the effect of the recommendations in the guidance for industry entitled "Drug-Induced Liver Injury: Premarketing Clinical Evaluation" since its publication in July 2009 and to seek suggestions for future revision.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →